By Stephen Nakrosis
Shares of Phreesia were trading at all-time lows in the after-hours market Monday, after the company cut its fiscal year 2027 revenue guidance.
After the closing bell, Phreesia said it was cutting guidance for FY27 revenue to $510 million to $520 million, from the previous range of $545 million to $559 million.
"As we discussed on our last earnings call in December 2025, we are experiencing shorter visibility into spending commitments by certain pharmaceutical manufacturers," Phreesia said.
Shares were trading at $9 after hours, down $21% from the day's regular session closing price of $11.41. On March 16, the stock touched a 52-week low of $10.75.
For the fourth quarter, Phreesia reported earnings per share of 2 cents on revenue of $127.1 million. In the year-ago period, the company had a loss per share of 11 cents on revenue of $109.7 million.
Phreesia provides patient check-in solutions for medical practices.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 30, 2026 17:13 ET (21:13 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.